Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009.
D000367:Age Factors; D006801:Humans; D007115:Immunization Schedule; D007252:Influenza Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D017780:Malaria Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D008458:Measles Vaccine / Q000009:adverse effects / Q000627:therapeutic use; D053918:Papillomavirus Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D022243:Rotavirus Vaccines / Q000008:administration & dosage / Q000009:adverse effects; D014612:Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D014944:World Health Organization
D007252:Influenza Vaccines; D017780:Malaria Vaccines; D008458:Measles Vaccine; D053918:Papillomavirus Vaccines; D022243:Rotavirus Vaccines; D014612:Vaccines